LAMASSU PHARMA
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis. Their lead candidate is a novel small molecule therapy for acute pancreatitis. This was developed at Mayo Clinic by leading scientists and has profound preclinical efficacy to completely mitigate mortality and morbidity associated with severe acute pancreatitis. We are currently focused on the continued development of this compound through safety testing in preparation for definitive clinical trials. Our ultimate goal is to save the lives of patients afflicted with this disease.
LAMASSU PHARMA
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Durham, North Carolina, United States
Country:
United States
Website Url:
http://www.lamassupharma.com
Total Employee:
1+
Status:
Active
Contact:
1-919-667-8571
Total Funding:
2.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Google
Current Employees Featured
Gabi Hanna CEO & Co-Founder @ Lamassu Pharma
CEO & Co-Founder
2019-10-01
Rabi Hanna CMO & Co-Founder @ Lamassu Pharma
CMO & Co-Founder
Greg Palmer CSO & Co-Founder @ Lamassu Pharma
CSO & Co-Founder
Founder
Official Site Inspections
http://www.lamassupharma.com
- Host name: redir.epik.com
- IP address: 209.196.144.25
- Location: Atlanta United States
- Latitude: 33.7485
- Longitude: -84.3871
- Metro Code: 524
- Timezone: America/New_York
- Postal: 30301
More informations about "Lamassu Pharma"
Home | Lamassu Pharma, LLC
At Lamassu, our team of dedicated physicians, engineers, and translational scientists, are driven by a passion to treat patients like family. Our goal is to speed the innovation process by bringing transformational treatments from …See details»
Lamassu Pharma - Crunchbase Company Profile & Funding
Lamassu Pharma is a biotech startup that solves the critical unmet medical need for severe acute pancreatitis. Their lead candidate is a novel small molecule therapy for acute pancreatitis. This …See details»
Lamassu Pharma - Overview, News & Similar companies - ZoomInfo
Lamassu Pharma contact info: Phone number: (919) 667-8571 Website: www.lamassupharma.com What does Lamassu Pharma do? Founded in 2018, Lamassu …See details»
Lamassu Pharma Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Lamassu Pharma Inc. of Durham, NC. Get the latest business insights from Dun & Bradstreet.See details»
Lamassu Pharma Company Profile 2024: Valuation, Funding
Developer of small molecule therapeutics designed to treat acute pancreatitis. The company's therapeutics mitigate the mortality and morbidity associated with severe acute pancreatitis, …See details»
Lamassu Pharma Inc. | VentureRadar
Website: https://www.lamassupharma.com/ Develops transformative medical treatments by advancing novel therapeutics through regulatory approval, fostering academia-industry …See details»
Lamassu Pharma - Craft
Lamassu Pharma (formerly PreClinical Pathfinder) is a biotech company that provides clinical trials and therapeutics services. It offers critical unmet medical needs for severe acute …See details»
Lamassu Pharma - Products, Competitors, Financials, Employees ...
Lamassu Pharma primarily serves the healthcare sector, with a focus on addressing unmet medical needs through rigorous scientific research and clinical development. It was founded in …See details»
Lamassu Pharma - Owler
Lamassu Pharma is a North Carolina-based biotechnology company that researches and develops small-molecule therapeutics for the treatment of acute pancreatitis. Lamassu …See details»
Lamassu Pharma (RB6PG7UNAKE3) - highergov.com
Lamassu Pharma (UEI RB6PG7UNAKE3, CAGE 8CVY4) based in Durham NC federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Meet another new biotech startup, Lamassu Bio, emerging from …
Mar 17, 2022 · There's a new biotech company in Durham, formed following the 'success' of Lamassu Pharma LLC, and it plans to accelerate R&D timelines to fight cancer.See details»
Lamassu Biotech | North Carolina Biotech Center
Lamassu Pharma is developing small molecule therapeutics to address unmet needs.See details»
Lamassu Pharma Announces Development of New Pancreatitis …
Apr 20, 2021 · RABI-767 is a novel small molecule lipase inhibitor licensed from the Mayo Foundation for medical education and research focused on filling a critical, unmet clinical need …See details»
Lamassu Pharma Receives Prestigious $1.5 Million NIH SBIRP …
DURHAM, N.C., July 14, 2020 /PRNewswire/ -- Lamassu Pharma LLC, a privately held Biotech announced today it has received $1.5 million in Small Business Innovation Research (SBIR) …See details»
Lamassu Pharma Inc. - VentureRadar
Website: https://www.lamassupharma.com/ Develops transformative medical treatments by advancing novel therapeutics through regulatory approval, fostering academia-industry …See details»
Lamassu Pharma Reviews | Read Client Reviews of Lamassu Pharma.
Read reviews of Lamassu Pharma. Write and share your personal story. Your experience will help others make the right buying decision.See details»
Lamassu Pharma Announces Development of New ... - Markets …
Apr 20, 2021 · RABI-767 is a novel small molecule lipase inhibitor licensed from the Mayo Foundation for medical education and research focused on filling a critical, unmet clinical need …See details»
Why Lamassu Pharma is developing a novel pancreatitis treatment
Aug 24, 2021 · Lamassu Pharma (Durham, N.C.) is developing a drug known as RABI-767 that could offer hope to patients with severe acute pancreatitis. The company is gearing up for a …See details»
Lamassu Pharma Announces Development of New Pancreatitis …
Apr 20, 2021 · RABI-767 is a novel small molecule lipase inhibitor licensed from the Mayo Foundation for medical education and research focused on filling a critical, unmet clinical need …See details»
Lamassu Bio Unveils New Venture to Accelerate Cancer Therapeutics
Mar 18, 2022 · Lamassu Bio, Inc., known as a team of “academicians-turned-biopharmaceutical disruptors,” is setting its sights on the unmet needs of the pharmaceutical industry as it …See details»